Earnings Feed
Start Free
INDEVUS PHARMACEUTICALS INC·4

Feb 4, 3:22 PM ET

MORVILLE MALCOLM 4

4 · INDEVUS PHARMACEUTICALS INC · Filed Feb 4, 2005

Insider Transaction Report

Form 4
Period: 2005-02-02
INDEVUS PHARMACEUTICALS INCIDEV
MORVILLE MALCOLM
Director
Transactions
  • Exercise of In-Money

    Common Stock, par value $.001 per share

    2005-02-02$2.38/sh+6,500$15,438→ 20,750 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2005-02-02$2.38/sh−6,500$15,438→ 0 total
    Exercise: $2.38From: 2002-04-05Exp: 2010-04-05→ Common Stock, par value $.001 per share (6,500 underlying)
  • Exercise of In-Money

    Common Stock, par value $.001 per share

    2005-02-02$2.36/sh+1,250$2,950→ 14,250 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2005-02-02$2.36/sh−1,250$2,950→ 3,750 total
    Exercise: $2.36From: 2004-03-12Exp: 2013-03-12→ Common Stock, par value $.001 per share (1,250 underlying)
Footnotes (2)
  • [F1]Represents exercise of stock options granted pursuant to the Company's 2000 Stock Option Plan.
  • [F2]Represents shares acquired through exercise of stock options granted pursuant to the Company's 2000 Stock Option Plan.

Documents

1 file
  • 4
    rrd67440.xmlPrimary